Research Where
the Decisions
Get Made.
SIS International runs primary market research across every US state and Canadian province with native field teams, owned focus group facilities in New York City, and bilingual panels for English, Spanish, and French-Canadian fieldwork.
North America Market Research That Survives Scrutiny
Most North America market research fails at the same point: the gap between what respondents say in a survey and what they actually do. SIS closes that gap by pairing quantitative instruments with ethnographic observation, shopper intercepts, and in-depth qualitative probing conducted by field teams who live in the markets they study.
The US and Canada present distinct regulatory, cultural, and competitive structures. A pharmaceutical launch strategy built on FDA timelines operates differently from one navigating Health Canada. Buy American procurement rules shape B2B purchasing in ways that don’t apply north of the border. Our practice accounts for these structural differences at the research design stage.
SIS has conducted primary research in North America for over four decades. Ruth Stanat founded the firm in New York, and our headquarters remain here.
All 50 States. Every Vertical.
From executive IDIs with procurement VPs in the Midwest to shopper intercepts in the Southeast, SIS fields research across the full US geography. We navigate FTC disclosure, CCPA data privacy, and SEC-adjacent research protocols.
Explore US Coverage
Every Province. Both Languages.
Quebec’s consumer behavior operates within a distinct cultural framework. Our Canadian practice fields French-Canadian focus groups with native Quebecois moderators and handles PIPEDA data privacy requirements.
Explore Canada CoverageWhat This Looks Like in Practice
Three engagements that illustrate how SIS fieldwork translates into client decisions.
A European Consumer Electronics Firm Entering the US Market
12 ethnographic in-home studies and 800-respondent conjoint revealed US buyers weighted after-sale service over technical specs.
A Mid-Cap Pharma Evaluating Biosimilar Competitive Threat
18 IDIs with PBMs and formulary committee members identified that mid-tier health plans would switch faster than national plans.
A Japanese Manufacturer Assessing US Distribution
25 distributor IDIs surfaced that frustration stemmed from post-CUSMA lead time increases, not pricing.
What Separates Our
North America Practice
Six structural advantages that protect data quality and deliver research your leadership team will trust.
SIS operates its own focus group and CLT facilities in New York City. Clients observe in real time.
Panels verified by employer, title, purchasing authority. Digital fingerprinting prevents duplicates.
Cognitive debriefing and cultural adaptation before fielding. Native moderators in each market.
Instruments designed for cross-border comparability accounting for FDA vs. Health Canada and CUSMA.
Ethnography, shopper intercepts, CATI/CAWI, conjoint, win/loss, CLT. Method fits the question.
CCPA, PIPEDA, FTC, SEC, HIPAA compliance managed at design stage.
What Does Your
Next Study Require?
Tell us the market, the vertical, the decision timeline, and the respondent profile. Our North America team will scope the right fieldwork design.
Talk to an Expert
KO 
EN 
AR 
ZH 
ZH_HK 
NL 
FR 
DE 
IT 
JA 
PL 
PT 
ES